Immunosuppression and Chagas disease: a management challenge.
Immunosuppression, which has become an increasingly relevant clinical condition in the last 50 years, modifies the natural history of Trypanosoma cruzi infection in most patients with Chagas disease. The main goal in this setting is to prevent the consequences of reactivation of T. cruzi infection b...
Main Authors: | María-Jesús Pinazo, Gerard Espinosa, Cristina Cortes-Lletget, Elizabeth de Jesús Posada, Edelweiss Aldasoro, Inés Oliveira, Jose Muñoz, Montserrat Gállego, Joaquim Gascon |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | http://europepmc.org/articles/PMC3547855?pdf=render |
Similar Items
-
Pulmonary infiltrates and eosinophilia in a 25-year-old traveler.
by: Jose Muñoz, et al.
Published: (2013-01-01) -
Altered Hypercoagulability Factors in Patients with Chronic Chagas Disease: Potential Biomarkers of Therapeutic Response.
by: Maria-Jesus Pinazo, et al.
Published: (2016-01-01) -
Chagas disease among the Latin American adult population attending in a primary care center in Barcelona, Spain.
by: Carme Roca, et al.
Published: (2011-04-01) -
Characterization of digestive involvement in patients with chronic T. cruzi infection in Barcelona, Spain.
by: María-Jesús Pinazo, et al.
Published: (2014-08-01) -
Chagas disease and immunosuppression
by: Marcelo Simão Ferreira
Published: (1999-09-01)